Isoproterenol Hydrochloride
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Isoproterenol Hydrochloride
- Generic name
- ISOPROTERENOL HYDROCHLORIDE
- Manufacturer
- Nordic Pharma, Inc.
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 046f2941-3bc0-4755-861c-71bedb49e706
- SPL ID
- 2da39a42-e4eb-4687-a660-6720e705ec75
- Version
- 2
- Effective date
- 2024-06-27
- Source export date
- 2026-09-28
- Source partition
- 9
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/6784607726c827491ceaeab30d843632e0660ee8008c535197be5ed9e1e52201/drug-label-0009-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:57:55
| Harmonized routes |
|---|
| INTRACARDIAC, INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | ANDA | 211237 | derived:openfda.application_number |
| application number | ANDA211237 | openfda.application_number | |
| brand name | Isoproterenol Hydrochloride | openfda.brand_name | |
| generic name | ISOPROTERENOL HYDROCHLORIDE | openfda.generic_name | |
| manufacturer name | Nordic Pharma, Inc. | openfda.manufacturer_name | |
| ndc | package | 69918-731-10 | openfda.package_ndc |
| ndc | package | 69918-735-10 | openfda.package_ndc |
| ndc | product | 69918-735 | openfda.product_ndc |
| ndc | product | 69918-731 | openfda.product_ndc |
| ndc11 | package | 69918073510 | derived:openfda.package_ndc |
| ndc11 | package | 69918073110 | derived:openfda.package_ndc |
| rxcui | 1667909 | openfda.rxcui | |
| rxcui | 1667915 | openfda.rxcui | |
| spl id | 2da39a42-e4eb-4687-a660-6720e705ec75 | id | |
| spl set id | 046f2941-3bc0-4755-861c-71bedb49e706 | set_id | |
| unii | DIA2A74855 | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
5 WARNINGS AND PRECAUTIONS Cardiac arrhythmias and ischemia may be induced by isoproterenol hydrochloride injection ( 5.1 ) Sulfite: Isoproterenol hydrochloride injection contains metabisulfite, which may cause allergic reaction ( 5.2 ) 5.1 Cardiac Arrhythmias and Ischemia Isoproterenol may induce cardiac arrhythmias and myocardial ischemia in patients, especially patients with coronary artery disease, or cardiomyopathy. 5.2 Allergic Reactions associated with Sulfite Isoproterenol hydrochloride injection contains sodium metabisulfite, which may cause mild to severe allergic reactions including anaphylaxis or asthmatic episodes, particularly in patients with a history of allergies. However, the presence of metabisulfite in this product should not preclude its use for treatment in emergency situations, even if the patient is sulfite-sensitive, as the alternatives to using isoproterenol in a life-threatening situation may not be satisfactory.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
6 ADVERSE REACTIONS The following adverse reactions have been associated with use of isoproterenol. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency reliably or to establish a causal relationship to drug exposure. Nervous system disorders: Nervousness, headache, dizziness, visual blurring Cardiovascular: Tachycardia, tachyarrhythmias, palpitations, angina, ventricular arrhythmias, Adams-Stokes attacks, pulmonary edema Respiratory: Dyspnea Other: Flushing of the skin, sweating, mild tremors, pallor, nausea Common adverse reactions with isoproterenol include tachycardia and palpitations ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact Nordic Pharma, Inc. at 1-844-267-4641 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.